4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001682068-26-000005
Options or other derivatives
- CHIEF FINANCIAL OFFICER acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Regnante Keith CHIEF FINANCIAL OFFICER | 2026-02-24 | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | D: show line 1 in the form |
Loading xslF345X05/form4-02262026_040214.xml…